Aveanna Expects Revenue To Grow 12.5-14% In FY22

Shares of Aveanna Healthcare Holdings Inc. (AVAH) are down over 60% year-to-date and trade around $2.71.

The company is a home care platform providing home healthcare services to more than 40,000 patients in 33 states in the U.S. Aveanna's services include private duty nursing, home health, hospice, medical solutions, and other essential healthcare services.

Between 2018 and 2021, the company's revenue has expanded at a CAGR of 10% while adjusted EBITDA, a measure for understanding a company's operating performance, has grown roughly 22%.

Revenue was $1.68 billion in full-year 2021 and adjusted EBITDA was $184.2 million.

For the first quarter ended April 2, 2022, adjusted net income declined to $7.37 million or $0.04 per share from $12.24 million or $0.08 in the year-earlier quarter.
Revenue increased 8% to $450.5 million in the first quarter of 2022 from $417.2 million in the year-earlier quarter.

Adjusted EBITDA was $38.0 million, or 8.4% of revenue, for the first quarter of 2022, as compared to $43.7 million, or 10.5% of revenue, for the first quarter of 2021.

Looking ahead to full-year 2022, the company expects revenue to range between $1.89 billion and $1.92 billion and adjusted EBITDA between $190 million and $205 million.

Aveanna shares began trading on the Nasdaq Global Market on April 29, 2021, priced at $12 each.

AVAH has traded in a range of $2.09 to $12.99 in the last 1 year. The stock closed Thursday's trading at $2.71, up 14.35%.

For comments and feedback contact: editorial@rttnews.com

Follow RTT